Logo The Business Journals
Politics2023-01-23 16:57:20
Cipla Ltd. wants to make generic versions of Research Triangle Park drugmaker Fennec's lone product.

Logo South China Morning Post
Business / FinanceBy Chad Bray2023-01-23 12:00:13
Japans Takeda Pharmaceutical will exclusively develop and manufacture fruquintinib outside mainland China, Hong Kong and Macau HutchMed will receive US$400...

Logo U.S. News & World Report
PoliticsBy Health Day2023-01-23 12:16:00
By Cara Murez HealthDay Reporter MONDAY, Jan. 23, 2023 (HealthDay News) Pharma bro Martin Shkreli may have violated a judges order banning him from being...

Logo EIN Presswire
HealthPress Release2023-01-23 21:16:52
ScanLeafs market penetration, along with additional licensing, further strengthens Valcons position in the European Medical Cannabis market. COPENHAGEN,...

Logo GlobeNewswire
SciencePress Release2023-01-23 08:00:00
HUTCHMED to receive US$400 million upfront on deal closing and up to US$730 million in potential future milestone payments, totaling up to US$1.13 billion,...

Logo The Business Journals
Politics2023-01-23 01:58:54
North Carolina is included among eight plaintiffs targeting pharma bro Martin Shkreli asking a federal judge to find him in contempt of court for starting...

Logo GlobeNewswire
SciencePress Release2023-01-23 18:25:00
Announced Earlier Today -Notice Received from ANDA Filer for FIRDAPSE CORAL GABLES, Fla., Jan. 23, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc....

Logo GlobeNewswire
SciencePress Release2023-01-23 14:20:00
Partnership Will Provide Pharmaceutical Grade Cannabinoid Active Ingredients to the Largest Pharmaceutical and Consumer Goods Names in the Industry BUFFALO,...

Logo GlobeNewswire
SciencePress Release2023-01-23 13:03:00
CORAL GABLES, Fla., Jan. 23, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (NASDAQ: CPRX), a commercial-stage biopharmaceutical...

Logo EIN Presswire
HealthPress Release2023-01-23 09:08:12
Douglas Insights The key competitors in the Global Compounding Pharmacies Market are B. Braun, Dougherty's Pharmacy, Institutional Pharmacy Solutions....

Logo PR Newswire
Shareholders with $150,000 losses or more are encouraged to contact the firm. LOS ANGELES, Jan. 23, 2023 /PRNewswire/ -- The Law Offices of Frank R. Cruz...

Logo The Business Journals
Business / Finance2023-01-23 19:27:11
The special purpose acquisition company taking Aprinoia Therapeutics public for $280 million was founded by Wilbur Ross, the former U.S. Secretary of...

Logo Nasdaq
Business / FinanceBy Rtt News2023-01-23 21:59:44
(RTTNews) - Shares of Axcella Therapeutics (AXLA) surged over 65% in extended session on Monday after the clinical-stage biotechnology company announced a...

Logo EIN Presswire
HealthPress Release2023-01-23 09:44:17
Pharmaceutical Container Market Growth 2023 Major players profiled in the report include Gerresheimer, AptarGroup, Berry Plastics Group, Amcor Limited, Alpha...

Logo GlobeNewswire
SciencePress Release2023-01-23 08:10:00
Newton Biocapital II Leads Funding Round For First-of-Its-Kind Drug to Treat Insulin Resistance First Breakthrough Addressing Insulin Resistance in Type 2...

Logo PR Newswire
HealthPress Release2023-01-23 07:00:00
HOLON, Israel, Jan. 23, 2023 /PRNewswire/ -- Estar Medical ® has been successful in revoking Regenlab's original patent for making platelet rich plasma (PRP)...

Logo Nasdaq
Business / FinanceBy Rtt News2023-01-23 12:10:29
(RTTNews) - British drug major AstraZeneca Plc. (AZN.L, AZN) Monday said it is commencing a tender offer to buy all shares of CinCor Pharma, Inc. (CINC), a...

Logo PR Newswire
NEW YORK, Jan. 23, 2023 /PRNewswire/ -- Attention Generac Holdings Inc. ("Generac") (NYSE: GNRC) shareholders: The Law Offices of Vincent Wong announce that...

Logo PR Newswire
HealthPress Release2023-01-23 16:56:00
HARLEYSVILLE, Pa., Jan. 23, 2023 /PRNewswire/ -- Colorcon, Inc., a global leader in pharmaceutical film coatings and specialty excipients, today announces...

Logo GlobeNewswire
NEW YORK and LONDON, Jan. 23, 2023 (GLOBE NEWSWIRE) -- CIIG Capital Partners II, Inc. (Nasdaq: CIIG) (CIIG II), a U.S. publicly-listed blank check company,...